A New Selective Pharmacological Enhancer of the Orai1 Ca<sup>2+</sup> Channel Reveals Roles for Orai1 in Smooth and Skeletal Muscle Functions
Iman Azimi(Australian Regenerative Medicine Institute), Gregory R. Monteith(The University of Queensland), Irina Vetter(Centre National de la Recherche Scientifique), William A. Denny(Maurice Wilkins Centre), Ryan E. Yoast(Pennsylvania State University), Silke B. Chalmers(The University of Queensland), Bradley S. Launikonis(The University of Queensland), Aldo Meizoso‐Huesca(The University of Queensland), Mohamed Trebak(Historical Society of Western Pennsylvania), Xuexin Zhang(Harbin Medical University), Benjamin P. Ross(The University of Queensland), Martin Johnson(Pennsylvania State University), Jeevak Sopanrao Kapure(The University of Queensland), Ralph J. Stevenson(University of Auckland), Mark Ashton(Newcastle University), Ping Xin(Beihua University), Jack U. Flanagan(University of Auckland)
Cited by 36
Related Papers
A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
|Nature Medicine|2015|2.8k
Methods Used to Evaluate Pain Behaviors in Rodents
|Frontiers in Molecular Neuroscience|2017|1.3k
Pathophysiology of Chemotherapy-Induced Peripheral Neuropathy
|Frontiers in Molecular Neuroscience|2017|654
Functional screening in human cardiac organoids reveals a metabolic mechanism for cardiomyocyte cell cycle arrest
|Proceedings of the National Academy of Sciences|2017|482
Conus Venom Peptide Pharmacology
|Pharmacological Reviews|2012|422